Breast cancer
Open
Phase 3
This trial is looking at adding MK-2870 to pembrolizumab after surgery for .
It is for people who:
have had standard chemotherapy and pembrolizumab before surgery
had cancer cells in tissue samples () taken at surgery
Recruitment start: 12 August 2024
Recruitment end: 25 October 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
Merck Sharp & Dohme Ltd
Last reviewed: 07 Jul 2025
CRUK internal database number: 19955
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
